Diffusion Pharmaceuticals takes aim at brain cancer: CEO David Kalergis

… diagnosed patients with high-grade primary brain cancer, glioblastoma multiforme (GBM). The data … chemotherapy-temozolomide-for newly diagnosed brain cancer. We are using temozolomide in … well as in metastatic brain cancer-not primary brain cancer, but cancer that arose …